Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
12-4-2020

Frequency and risk factors of acute kidney injury during diabetic
ketoacidosis in children and association with neurocognitive
outcomes
Sage R. Myers
Perelman School of Medicine

Kimberly S. Quayle
Washington University School of Medicine in St. Louis

et al

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Myers, Sage R.; Quayle, Kimberly S.; and et al, ,"Frequency and risk factors of acute kidney injury during
diabetic ketoacidosis in children and association with neurocognitive outcomes." JAMA Network Open.
3,12. . (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9843

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Original Investigation | Emergency Medicine

Frequency and Risk Factors of Acute Kidney Injury During Diabetic Ketoacidosis
in Children and Association With Neurocognitive Outcomes
Sage R. Myers, MD, MSCE; Nicole S. Glaser, MD; Jennifer L. Trainor, MD; Lise E. Nigrovic, MD, MPH; Aris Garro, MD, MPH; Leah Tzimenatos, MD; Kimberly S. Quayle, MD;
Maria Y. Kwok, MD, MPH; Arleta Rewers, MD, PhD; Michael J. Stoner, MD; Jeff E. Schunk, MD; Julie K. McManemy, MD, MPH; Kathleen M. Brown, MD;
Andrew D. DePiero, MD; Cody S. Olsen, MS; T. Charles Casper, PhD; Simona Ghetti, PhD; Nathan Kuppermann, MD, MPH;
for the Pediatric Emergency Care Applied Research Network (PECARN) DKA FLUID Study Group

Abstract

Key Points

IMPORTANCE Acute kidney injury (AKI) occurs commonly during diabetic ketoacidosis (DKA) in
children, but the underlying mechanisms and associations are unclear.

Question What are the mechanisms,
risk factors, and outcomes associated
with acute kidney injury (AKI) during

OBJECTIVE To investigate risk factors for AKI and its association with neurocognitive outcomes in

pediatric diabetic ketoacidosis (DKA)?
Findings In this cohort study using data

pediatric DKA.

from 1359 DKA episodes in a large,

DESIGN, SETTING, AND PARTICIPANTS This cohort study was a secondary analysis of data from

multicenter, prospective study of fluid

the Pediatric Emergency Care Applied Research Network Fluid Therapies Under Investigation in DKA

treatment during DKA, AKI occurred in

Study, a prospective, multicenter, randomized clinical trial comparing fluid protocols for pediatric

43% of episodes and was associated

DKA in 13 US hospitals. Included DKA episodes occurred among children age younger than 18 years

with greater acidosis and greater

with blood glucose 300 mg/dL or greater and venous pH less than 7.25 or serum bicarbonate level

circulatory volume depletion. Children

less than 15 mEq/L.

who had AKI were more likely to have
subtle cognitive impairment during DKA
and lower IQ at longer-term follow-up.

EXPOSURES DKA requiring intravenous insulin therapy.

Meaning These findings suggest that

MAIN OUTCOMES AND MEASURES AKI occurrence and stage were assessed using serum
creatinine measurements using Kidney Disease: Improving Global Outcomes criteria. DKA episodes
with and without AKI were compared using univariable and multivariable methods, exploring
associated factors.

AKI is frequent in pediatric DKA and
there is a pattern of multiorgan
dysfunction during childhood DKA with
the possibility of common
pathophysiologic mechanisms.

RESULTS Among 1359 DKA episodes (mean [SD] patient age, 11.6 [4.1] years; 727 [53.5%] girls; 651
patients [47.9%] with new-onset diabetes), AKI occurred in 584 episodes (43%; 95% CI, 40%-46%).
A total of 252 AKI events (43%; 95% CI, 39%-47%) were stage 2 or 3. Multivariable analyses
identified older age (adjusted odds ratio [AOR] per 1 year, 1.05; 95% CI, 1.00-1.09; P = .03), higher
initial serum urea nitrogen (AOR per 1 mg/dL increase, 1.14; 95% CI, 1.11-1.18; P < .001), higher heart

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

rate (AOR for 1-SD increase in z-score, 1.20; 95% CI, 1.09-1.32; P < .001), higher glucose-corrected
sodium (AOR per 1 mEq/L increase, 1.03; 95% CI, 1.00-1.06; P = .001) and glucose concentrations
(AOR per 100 mg/dL increase, 1.19; 95% CI, 1.07-1.32; P = .001), and lower pH (AOR per 0.1 increase,
0.63; 95% CI, 0.51-0.78; P < .001) as variables associated with AKI. Children with AKI, compared with
those without, had lower scores on tests of short-term memory during DKA (mean [SD] digit span
recall: 6.8 [2.4] vs 7.6 [2.2]; P = .02) and lower mean (SD) IQ scores 3 to 6 months after recovery from
DKA (100.0 [12.2] vs 103.5 [13.2]; P = .005). Differences persisted after adjusting for DKA severity
and demographic factors, including socioeconomic status.
(continued)
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Abstract (continued)

CONCLUSIONS AND RELEVANCE These findings suggest that AKI may occur more frequently in
children with greater acidosis and circulatory volume depletion during DKA and may be part of a
pattern of multiple organ injury involving the kidneys and brain.
JAMA Network Open. 2020;3(12):e2025481. doi:10.1001/jamanetworkopen.2020.25481

Introduction
Recent studies have shown that the incidence of organ injuries in children with diabetic ketoacidosis
(DKA) is substantially higher than previously appreciated.1-4 Subtle cerebral injuries occur commonly
in children with DKA, which result in long-term cognitive alterations.1-4 Although the mechanisms
of cerebral injury in DKA are under investigation, evidence supports a role for hypoperfusion and
reperfusion injury as well as cerebral inflammation associated with DKA in children.5-9
One recent study demonstrated that acute kidney injury (AKI) commonly occurs in children with
DKA. In a 2017 retrospective cohort study of 165 children with DKA,10 64% developed AKI. In that
study,10 AKI was reported to be more common in children with low serum bicarbonate levels,
tachycardia, and hypernatremia, suggesting that severe dehydration and acidosis may play roles in
triggering kidney injury. These risk factors are similar to those associated with cerebral injury during
DKA,11-13 raising the question of whether factors associated with DKA severity are independently
associated with increased risk of injury to multiple organs, or whether kidney and cerebral injuries
during DKA might involve a single pathophysiological process. Isolated cases of severe multiple organ
dysfunction syndrome during DKA have been reported14; however, a pathophysiological connection
between DKA-related kidney injury and injury to the brain or other organs has not previously been
established, to our knowledge.
Long-term cognitive changes after DKA support the possibility that acute organ injury in DKA
could lead to chronic organ dysfunction.1-3,15 Furthermore, in other childhood diseases, AKI is
associated with increased risk of chronic kidney disease in adulthood, particularly when repeated
episodes occur.16,17 Therefore, additional study of AKI during DKA is important to better understand
how to prevent AKI during DKA and to consider possible associations with chronic diabetic kidney
disease. In this cohort study, we evaluated the frequency of and factors associated with AKI using
data from a large, prospective study of pediatric DKA. We hypothesized that subtle kidney injuries
occur commonly in children during DKA and may be associated with cerebral injury.

Methods
This cohort study was a secondary analysis of a multicenter prospective study comparing effects of
fluid infusion rate and sodium content on neurocognitive outcomes in children with DKA, the
Pediatric Emergency Care Applied Research Network (PECARN) Fluid Therapies Under Investigation
in DKA (FLUID) trial.18 The PECARN FLUID trial involved 13 emergency departments in PECARN and
was approved by the institutional review boards of participating institutions, and informed assent
was obtained for all patients. Our planned secondary analysis was included in approval and assent.
The PECARN FLUID trial included patients younger than 18 years with episodes of DKA (blood
glucose concentration of >300 mg/dL [to convert to millimoles per liter, multiply by 0.0555] and
venous pH <7.25 or serum bicarbonate concentration <15 mEq/L [to convert to millimoles per liter,
multiply by 1]). We determined the presence of AKI during DKA in all episodes with height and
creatinine data available. This study is reported following the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline.
The PECARN FLUID Trial compared 4 fluid rehydration protocols.18 Exclusion criteria are
described elsewhere18,19 and included conditions unrelated to DKA that affect mental status or
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cognition or substantial treatment for DKA before evaluation. Mental status during DKA was
assessed hourly using Glasgow Coma Scale (GCS) scores, and short-term memory (digit span recall
testing) was assessed every 4 hours during waking hours. Children 3 years and older returned for
neurocognitive testing 2 to 6 months after the DKA episode, as described previously.18,19 This
assessment included evaluation of long-term memory, IQ (Wechsler Abbreviated Scale of Intelligence
for children age ⱖ6 years, Wechsler Preschool and Primary Scale of Intelligence for children age 3-5
years), and short-term memory (digit-span recall).18-22
Episodes of AKI were defined by the Kidney Disease: Improving Global Outcomes serum
creatinine criteria.23 Baseline creatinine values were not available for most episodes, and most
previous creatinine values in medical records were measured during illnesses. We therefore used an
estimated glomerular filtration rate (eGFR) of 120 mL/min/1.73 m2 to calculate expected baseline
creatinine levels for all DKA episodes using the Schwartz estimating equation.10,24-26 An eGFR of 120
mL/min/1.73 m2 was chosen for consistency with other studies of pediatric AKI10,24,25; however, we
conducted sensitivity analyses using eGFRs of 90 mL/min/1.73 m2 and 110 mL/min/1.73 m2.10,26 For
AKI stages 1, 2, and 3, we used Kidney Disease: Improving Global Outcomes creatinine cutoffs of 1.5-,
2-, and 3-fold estimated baseline creatinine, respectively.23 The maximum serum creatinine
measured was used to define AKI. The first serum creatinine measured prior to initiation of DKA
treatment was used to determine AKI at presentation.
Percentage dehydration was defined as the percentage difference between weight at
presentation and discharge. Corrected sodium was defined as the serum sodium concentration
(mEq/L) plus a factor derived using blood glucose (mg/dL) measured within 30 minutes
(1.6 × [(Glucose − 100) / 100]). Heart rate and blood pressure were standardized as z-scores,27,28
indicating the number of SDs a measurement differed from the mean for age and sex. Blood pressure
z-scores were additionally adjusted for height. Concomitant medications were reviewed to identify
medications with potential nephrotoxic effects (eg, nonsteroidal anti-inflammatory drugs, statins,
aspirin, cyclosporin, ciprofloxacin, trimethoprim/sulfamethoxazole, acyclovir, vancomycin,
daptomycin, and furosemide). Clinically apparent cerebral injury was defined by a deterioration in
neurological status leading to hyperosmolar therapy or endotracheal intubation or resulting
in death.12,29

Statistical Analyses
The primary analyses investigated factors associated with AKI during DKA using univariable
comparisons and multivariable models. In secondary analyses, we investigated factors associated
with AKI in specific patient subgroups, including those with previously diagnosed diabetes and
patients for whom information was available on dehydration severity. Additional secondary analyses
included sensitivity analyses varying the assumptions used to estimate baseline creatinine
concentrations, and analyses exploring likelihood of AKI in repetitive DKA episodes among patients
enrolled in the study with 2 episodes (per protocol, patients could be enrolled in the study no more
than twice; however, 2 patients were inadvertently enrolled 3 times).
We described DKA episodes with and without AKI using means and SDs for continuous
characteristics and frequencies and percentages for categorical characteristics. We compared AKI to
non-AKI groups using logistic regression models. Diabetes duration and previous DKA diagnoses
were compared for patients with previously diagnosed diabetes. To account for delays in result
reporting, AKI was considered prior to treatment if laboratory criteria were met within 2 hours of
treatment initiation, if there were no results prior.
We used a multivariable logistic regression model to estimate adjusted associations of
demographic, clinical, and biochemical factors with AKI. The model included covariate adjustments
for age, sex, and new-onset vs previously diagnosed diabetes. Baseline laboratory measurements
were included as indicators associated with DKA severity (ie, serum urea nitrogen [SUN], glucosecorrected sodium, glucose and bicarbonate concentrations, PCO2, pH). Baseline heart rate z-score
was included as an indicator of intravascular volume. Blood pressure was not included because blood
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pressure is often paradoxically elevated in children with DKA and is not a good indicator of
intravascular volume.30 Diabetes duration and previous DKA episodes were not included because
these data apply only to patients with previously diagnosed diabetes. The final model did not include
dehydration severity owing to frequent missing data. Multivariable models were used for analyses
of subgroups. Associations between AKI in initial and subsequent DKA episodes were analyzed using
univariable and multivariable logistic regression adjusting for age, sex, and DKA severity (assessed
by baseline serum bicarbonate) at the second enrollment.
We estimated associations between AKI and neurocognitive outcomes using conditional
multivariable logistic regression (by enrolling hospital) to compare GCS declines (ie, GCS <14)
between AKI groups. We used a cumulative logistic model to evaluate differences in the magnitude
of GCS declines between groups, adjusting for the same covariates. We tested for an association
between AKI and clinically-apparent cerebral injury using a χ2 test. Forward and backward digit-span
recall test scores at baseline and follow-up and color and spatial task memory scores were compared
between AKI groups using mixed linear regression models including random effect of enrolling
hospital. IQ was compared between AKI groups using a mixed linear regression model.
A significance level of .05 was used for all statistical tests. We did not adjust significance levels
for multiple tests; therefore, analyses of secondary outcomes should be considered exploratory.
Analyses were performed using SAS statistical software version 9.4 (SAS Institute) from July to
December 2019, with verification of results occurring as recently as October 2020.

Results
Frequency of AKI
Of 1389 DKA episodes in the PECARN FLUID trial, 1359 were included in this analysis. A total of 30
DKA episodes (2.2%) with missing data were excluded, including 28 missing patient height and 2
missing creatinine level (Figure 1). The mean (SD) age of participants was 11.6 (4.1) years, 727 (53.5%)
were girls, and 651 (47.9%) had new onset of diabetes. AKI occurred in 584 DKA episodes (43.0%),
and 553 of these episodes (94.7%) presented with AKI at diagnosis of DKA. An additional 22
episodes (3.8%) demonstrated AKI during treatment after having normal kidney function prior to
treatment initiation, including 12 episodes in the fast rehydration subgroup and 10 episodes in the
slow rehydration subgroup. The timing of AKI was unknown for the remaining 9 episodes (1.5%) for
which first documented creatinine was more than 2 hours after treatment initiation. AKI developed
24 hours or longer after treatment initiation in 3 episodes (Figure 2). The maximum AKI stage
reached was stage 1 in 332 episodes (56.8%), stage 2 in 215 episodes (36.8%), and stage 3 in 37
episodes (6.3%). In 16 episodes (2.7%), AKI stage worsened during DKA treatment, including 7

Figure 1. Patient Flow Diagram

1389 Randomized in the
PECARN FLUID DKA study

30 Excluded
28 Missing height
2 Missing creatinine

1359 Analyzed

333 Fast rehydration
with 0.45% NaCl

347 Fast rehydration
with 0.9% NaCl

337 Slow rehydration
with 0.45% NaCl

342 Slow rehydration
with 0.9% NaCl
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episodes in the fast rehydration subgroup and 9 episodes in the slow rehydration subgroup. No
patients required dialysis.

Factors Associated With AKI
Univariable Analyses
We identified multiple patient characteristics and markers of DKA severity associated with AKI in
univariable analyses (Table 1). AKI was more common among children with previously diagnosed
diabetes compared with those with new onset (odds ratio [OR], 2.67; 95% CI, 2.14-3.34; P < .001),
and children with AKI were older than those without (OR per 1 year, 1.07; 95% CI, 1.04-1.10; P < .001).
Children with AKI were more acidotic and had higher initial glucose and sodium concentrations than
those without AKI, and PCO2 levels in children with AKI were higher than those without AKI, although
respiratory rates were also higher in the AKI group (Table 1). Children with AKI also had more severe
dehydration and higher initial heart rates, suggesting greater volume depletion.
Multivariable and Sensitivity Analyses
In multivariable analyses, older age (adjusted OR [AOR] per 1 year, 1.05; 95% CI, 1.00-1.09; P = .03),
higher initial SUN (AOR per 1 mg/dL increase, 1.14; 95% CI, 1.11-1.18; P < .001), higher heart rate (AOR
per 1-SD increase in z-score, 1.20; 95% CI, 1.09-1.32; P < .001), higher glucose-corrected sodium (AOR
per 1 mEq/L increase, 1.03; 95% CI, 1.00-1.06; P = .047) and higher glucose concentrations (AOR per
100 mg/dL increase, 1.19; 95% CI, 1.07-1.32; P = .001), and lower pH (AOR per 0.1 increase, 0.63; 95%
CI, 0.51-0.78; P < .001) were associated with higher risk of AKI (Table 2). Sensitivity analyses using
more conservative definitions of baseline kidney function (eGFR of 90 mL/min/1.73 m2 or 110
mL/min/1.73 m2) found lower estimated AKI frequencies (90 mL/min/1.73 m2: 252 patients [18.5%];
110 mL/min/1.73 m2: 440 patients [32.4%]); however, SUN, pH, glucose and heart rate continued to
be significantly associated with AKI in all analyses (eTable 1 in the Supplement). Analyses of patients
with previously diagnosed diabetes and patients for whom data on percentage dehydration (based
on weight change) were available also yielded similar results (eTable 2 and eTable 3 in the
Supplement). Patients reported receiving medications with possible nephrotoxic effects prior to
detection of AKI in only 3 of 584 DKA episodes with AKI (all stage 1).

Risk of AKI With Repeated DKA Episodes
A total of 130 DKA episodes (9.6%) were repeat enrollments of patients presenting with more than 1
episode. When we compared AKI status at the first and second enrollments, the odds of AKI were

Figure 2. Timing of Initial Detection of Acute Kidney Injury and Impaired Mental Status
Time of first abnormal ratio of creatinine to estimated baseline creatinine
Time of first abnormal mental status (confirmed GCS <14)
600

DKA episodes, No.

500

400

300

200

100

0
<2

2 to <6

6 to <12

12 to <18

≥24

Time after initiation of fluid treatment, h
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6.8-fold higher when the patient experienced AKI at the prior enrollment (OR, 6.80; 95% CI, 3.0814.97). After adjusting for illness severity and demographic factors (ie, age, sex, and serum
bicarbonate concentration at second enrollment), the AOR of AKI was even higher when the patient
experienced AKI at the prior enrollment (AOR, 9.12; 95% CI, 3.65-22.79).

Table 1. Patient and DKA Episode Characteristics
Mean (SD)a
Characteristic

No AKI
(n = 775)

AKI
(n = 584)

OR
(95% CI)b

P value

Age at screening, y

11.1 (4.1)

12.2 (4.0)

1.07 (1.04-1.10)

<.001

Boys

333 (43.0)

299 (51.2)

1.39 (1.12-1.73)

Girls

442 (57.0)

285 (48.8)

1 [Reference]

No

451 (58.2)

200 (34.2)

1 [Reference]

Yes

324 (41.8)

384 (65.8)

2.67 (2.14-3.34)

4.7 (3.3)

5.0 (3.2)

1.02 (0.98-1.07)

Sex, No. (%)
.003

Previously diagnosed with diabetes, No. (%)

Time since onset of diabetes, y

<.001
.33

Abbreviations: AKI, acute kidney injury; SUN, serum
urea nitrogen; DKA, diabetic ketoacidosis; NA, not
applicable; OR, odds ratio.

.04

SI conversion factors: To convert SUN to millimoles per
liter, multiply by 0.357; serum sodium concentration
to millimoles per liter, multiply by 1; serum bicarbonate
to millimoles per liter, multiply by 1; PCO2 to kilopascals,
multiply by 0.133; and serum glucose concentration to
millimoles per liter, multiply by 0.0555.

Previous DKA diagnoses, No. (%)
0

73 (22.7)

112 (29.5)

1 [Reference]

1-2

130 (40.5)

159 (41.8)

0.80 (0.55-1.16)

>2

118 (36.8)

109 (28.7)

0.60 (0.41-0.89)

SUN, mg/dL

14 (5)

21 (8)

1.16 (1.14-1.19)

<.001

Serum sodium concentration (corrected
for glucose), mEq/L

140 (4)

142 (6)

1.09 (1.06-1.11)

<.001

Serum bicarbonate, mEq/L

9 (3)

8 (3)

0.92 (0.89-0.95)

<.001

Baseline laboratory values

PCO2, mm Hg

26 (7)

27 (8)

1.02 (1.00-1.03)

.01

pH

7.19 (0.09)

7.13 (0.11)

0.55 (0.49-0.62)

<.001

489 (132)

565 (176)

1.41 (1.31-1.53)

<.001

Dehydration, % weight change

Serum glucose concentration, mg/dL

5.0 (3.7)

5.9 (4.1)

1.06 (1.03-1.10)

<.001

Respiratory rate at presentation

23.9 (6.0)

26.0 (7.8)

1.57 (1.33-1.86)

<.001

Heart rate, z-score at presentation

2.5 (1.7)

3.8 (1.6)

1.52 (1.42-1.64)

<.001

a

Missing data for previous DKA diagnoses (no AKI: 3
episodes; AKI: 4 episodes), SUN (no AKI: 59
episodes; AKI: 17 episodes), sodium (no AKI: 33
episodes; AKI: 23 episodes), bicarbonate (no AKI: 19
episodes; AKI: 11 episodes), PCO2 (no AKI: 36
episodes; AKI: 23 episodes), pH (no AKI: 34 episodes;
AKI: 20 episodes), dehydration (no AKI: 152
episodes; AKI: 105 episodes), respiratory rate (28
episodes; AKI: 14 episodes), heart rate (no AKI: 27
episodes; AKI: 15 episodes), systolic and diastolic
blood pressure (no AKI: 37 episodes; AKI: 14
episodes).

b

Unadjusted odds ratios compare the odds of AKI (vs
No-AKI) to the reference level for categorical
characteristics, a 0.1 unit change for pH, a 10-unit
change in respiratory rate, a 100 unit change in
serum glucose concentration, or a 1-unit change in
other continuous characteristics.

Blood pressure, z-score at presentation
Systolic

1.2 (1.2)

1.3 (1.4)

1.09 (1.00-1.18)

.06

Diastolic

1.0 (1.0)

0.9 (1.1)

0.91 (0.83-1.01)

.08

88 (11.4)

88 (15.1)

1.39 (1.01-1.90)

.04

Before development of AKI, % with
nephrotoxic meds

NA

3 (0.5)

NA

NA

After development of AKI, % with
nephrotoxic meds

NA

85 (14.6)

NA

NA

Medications with possible nephrotoxic effects,
No. (%)

Table 2. Factors Associated With Acute Kidney Injurya
Variable

AOR (95% CI)

P value

Age at screening, per 1-y

1.05 (1.00-1.09)

.03

Sex (boys vs girls)

1.27 (0.96-1.69)

.10

Previously diagnosed with diabetes (yes vs no)

1.12 (0.79-1.60)

.53

SUN, per 1 mg/dL

1.14 (1.11-1.18)

<.001

Serum sodium (corrected for glucose), per 1 mEq/L

1.03 (1.00-1.06)

.047

Bicarbonate, per 1 mEq/L

1.02 (0.94-1.11)

.62

PCO2, per 1 mm Hg

1.00 (0.97-1.03)

<.99

pH, per 0.1 increase

0.63 (0.51-0.78)

<.001

Serum glucose concentration, per 100 mg/dL increase

1.19 (1.07-1.32)

.001

1.20 (1.09-1.32)

<.001

Baseline laboratory value

Abbreviations: AOR, adjusted odds ratio; SUN, serum
urea nitrogen.
a

Heart rate z-score at presentation, per 1-SD increase

JAMA Network Open. 2020;3(12):e2025481. doi:10.1001/jamanetworkopen.2020.25481 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 12/06/2020

Results are from a multivariable logistic regression
model adjusting for each predictor in the table and
no others.
December 4, 2020

6/12

JAMA Network Open | Emergency Medicine

Acute Kidney Injury During Diabetic Ketoacidosis in Children and Neurocognitive Outcomes

Associations Between AKI and Cerebral Injury
Among 772 DKA episodes without AKI, GCS scores decreased below 14 in 14 episodes (1.8%), and of
559 DKA episodes with AKI, GCS scores decreased below 14 in 33 episodes (5.9%), but these
differences were not significant in multivariable analysis (P = .41). However, short-term memory
scores during DKA were significantly lower in patients who experienced DKA episodes with AKI
compared with those who did not (mean [SD] forward digit span score, 7.6 [2.2] vs 6.8 [2.4]; P = .02)
(Table 3). In 11 DKA episodes with AKI (1.9%) and 1 episode without AKI (0.1%), the patient developed
clinically apparent cerebral injury (unadjusted P < .001). Additionally, patients who had AKI,
compared with those without, had lower IQ scores after recovery (mean [SD score, 100.0 [12.2] vs
103.5 [13.2]; P = .005) (Table 3). These differences persisted after adjusting for demographic factors,
including socioeconomic status, and for DKA severity. Differences in IQ were mainly noted in patients
with new-onset diabetes (mean [SD] IQ score: patients with AKI, 101.4 [11.9]; patients without AKI,
106.6 [13.1]; P = .005) (Table 3).

Table 3. Associations Between AKI During DKA Treatment and Neurocognitive Outcomes
Mean (SD)
Outcomea

No AKI

AKI

Adjusted
analysis P value

Confirmed decline in GCS score to <14, No. (%)

14 (1.8)

33 (5.9)

.41b

0-1

756 (97.5)

529 (90.6)

2-3

12 (1.5)

30 (5.1)

≥4

7 (0.9)

25 (4.3)

Forward

7.6 (2.2)

6.8 (2.4)

.02d

Backward

5.8 (2.2)

5.2 (2.4)

.06d

103.5 (13.2)

100.0 (12.2)

.005e

Among new onset patients

106.6 (13.1)

101.4 (11.9)

.005e

Among previously diagnosed patients

98.9 (12.1)

99.0 (12.4)

.14e

Color task

0.5 (0.2)

0.5 (0.2)

.22d

Spatial task

0.7 (0.2)

0.7 (0.2)

.95d

Forward

8.1 (2.2)

8.2 (2.2)

.98d

Backward

6.7 (2.2)

6.9 (2.3)

.92d

Magnitude of decline in GCS score, No. (%)

.23c

Baseline digit-span recall test score

IQ score

Memory score

Follow-up digit-span recall test

Abbreviations: AKI, acute kidney injury; DKA, diabetic ketoacidosis; GCS, Glasgow Coma Scale.
a

Numbers of patients with outcome data are 772 patients without AKI and 559 patients with AKI for GCS decline, 775
patients without AKI and 584 patients with AKI for magnitude of GCS decline, 696 patients without AKI and 530 patients
with AKI for baseline forward digit span recall, 695 patients without AKI and 527 patients with AKI for baseline backward
digit span, 501 patients without AKI and 344 patients with AKI for full scale IQ, 301 patients without AKI and 136 patients
with AKI for full scale IQ among new onset patients, 200 patients without AKI and 208 patients with AKI for full scale
IQ among previously diagnosed patients, 464 patients without AKI and 319 patients with AKI for item color rate, 456
patients without AKI and 320 patients with AKI for item space rate, 519 patients without AKI and 356 patients with AKI
for forward digit span recall at follow-up, and 518 patients without AKI and 356 patients with AKI for backward digit span
recall at follow-up.

b

P value from conditional logistic regression model adjusting for enrolling center, assigned treatment rate and sodium
concentration, new onset, age, sex, and baseline SUN, PCO2, pH, and sodium and glucose concentrations.

c

P value from cumulative logit regression model adjusting for assigned treatment rate and sodium concentrations, new
onset, age, sex, and baseline SUN, PCO2, pH, and sodium and glucose concentrations.

d

P value from mixed linear regression model adjusting for random effect of site and fixed effects of new onset, age, sex,
socioeconomic status, and baseline SUN, PCO2, pH, and sodium and glucose concentrations; the effect of site was
dropped from the new onset model to achieve model convergence.

e

P value from mixed linear regression model adjusting for random effect of site and fixed effects of new onset, sex,
instrument, socioeconomic status, and baseline SUN, PCO2, pH, sodium and glucose concentrations. Site was not
included in the new onset patient model to facilitate model convergence.
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Discussion
The results of this cohort study agree with previous findings that AKI is common in children with DKA
and that nearly half of children with AKI had severe AKI (stage 2 or 3), suggesting intrinsic tubular
injury beyond prerenal azotemia. This cohort study found that AKI was associated with greater
acidosis and circulatory volume depletion, similar to associations with cerebral injury during DKA.11-13
Of note, children with AKI had higher frequencies of subtle cognitive impairment during DKA, and
deficits in IQ were evident in children with AKI after DKA recovery compared with children without
AKI. Importantly, IQ differences between children with and without AKI persisted after adjusting for
DKA severity and demographic factors. Although the observed IQ differences were subtle, cognitive
deficits associated with DKA may become greater over time.1 Therefore, detection of any deficits in
cognition shortly after DKA recovery is of concern. Our data suggest that AKI during DKA may occur
as part of a pattern of multiple organ injury involving both kidneys and brain.
The rate of AKI in our study was lower than the rate of 64.2% found in a smaller, retrospective
single-center study by Hursh et al.10 This difference might reflect differences in cohort inclusion
between the studies, particularly more severe DKA (lower mean pH values) in the retrospective
group compared with our prospective cohort. Regardless, both studies confirm a high frequency of
AKI during pediatric DKA.
Most patients with AKI presented with AKI prior to DKA treatment; however, 4% of patients
presented with normal kidney function and developed AKI during DKA treatment, and 3% of patients
had worsening of AKI during treatment. A similar frequency of progression of AKI during DKA
treatment was also found in a small clinical trial by Williams et al.31 Similar to cerebral injury during
DKA, AKI can develop as late as 12 to 24 hours after initiating DKA treatment. The development or
worsening of AKI during treatment, when hydration status should be improving, suggests that some
AKI in DKA may not result from prerenal mechanisms.
Our analyses indicate that AKI was associated with more severe acidosis and dehydration
(higher glucose levels, heart rates, and SUN) similar to the study by Hursh et al.10 More importantly,
we found an association between AKI and signs of cerebral injury, both during DKA treatment
(alterations in short-term memory) and several months later (lower IQ scores). To our knowledge,
these data are the first to demonstrate this association during DKA in children. Although occurrence
of hypotension in children with DKA might explain concurrent AKI and cerebral injury, previous
analyses of the study database demonstrated that hypotension occurred rarely (0.2% of patients at
presentation and 3.3% of patients during DKA treatment); therefore, hypotension is unlikely to be
involved.30 Furthermore, the association between AKI and cerebral injury persisted after adjusting
for multiple aspects of DKA severity, suggesting that concurrent kidney and cerebral injury were
associated with a common process and not simply reflections of a higher risk of injury to both organs
in children with more severe DKA.
The cause of organ injuries in children with DKA is still poorly understood. Cerebral injury has
been the most extensively studied. Although cerebral injury was previously assumed to be caused by
osmotic shifts resulting from extreme hyperglycemia and rapid rehydration, recent data suggest that
other mechanisms are more likely, including hypoperfusion and reperfusion injury, and damage
resulting from inflammatory mechanisms.5-9 Decreased kidney perfusion likely contributes to AKI in
DKA; however, evidence of cerebral inflammatory injury,7 and the association of AKI with cognitive
dysfunction, raises the possibility of more diffuse inflammatory organ injuries, a physiological
process that has not been studied in DKA, to our knowledge. Interestingly, in animal models, diabetes
worsens kidney injury from ischemic events, and inflammatory mechanisms have been proposed to
explain this association.32 Basal vacuolization of kidney tubular epithelial cells is a marker of
ketoacidosis on autopsy, suggesting direct kidney injury in severe DKA.33 In addition, early diabetic
kidney disease involves interstitial inflammation, including mononuclear cell invasion.34 These
findings suggest a possible mechanism connecting acute and chronic kidney disease.32-34
Interestingly, among patients who enrolled in the study twice, AKI during the first DKA episode was
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significantly associated with the risk of occurrence of AKI during the second episode. These
associations persisted after adjusting for severity of acidosis and demographic factors, suggesting
either that AKI reflects specific inflammatory responses to DKA that vary among individuals or that
prior episodes of AKI increase the susceptibility of the kidneys to further injury. Evaluation of factors
associated with risk of AKI during DKA should be considered given these possible novel mechanisms.

Limitations
This study has some limitations. The timing of blood sample collection varied among sites, and
creatinine level frequently was not measured after acidosis resolved. Therefore, some AKI episodes
may have been missed or may have occurred earlier. In addition, baseline creatinine measurements
were not available for most patients and were therefore estimated. The ideal eGFR to determine
baseline creatinine is controversial. We used an eGFR of 120 mL/min/1.73 m2 to be consistent with
other pediatric AKI studies10,24,25; however, lower values have also been used. Sensitivity analyses
using 110 mL/min/1.73 m2 and 90 mL/min/1.73 m2 yielded lower estimates of AKI frequency;
however, clinical and biochemical associations were similar in all analyses. In addition, the frequency
of clinically apparent cerebral injury in DKA is low and we relied on mental status and cognition as
indicators of subtle cerebral injury. The extent to which subtle cognitive alterations during DKA were
associated with more overt cerebral injury is unverified; however, the detection of deficits in IQ after
recovery provides more convincing evidence of associations between AKI and cerebral injury.
Additionally, use of potentially nephrotoxic medications prior to hospitalization was incompletely
recorded; however, use of these medications in children with diabetes is uncommon. Furthermore,
whether DKA influences development of chronic diabetic kidney disease is unknown. Data on urine
microalbumin levels before and after DKA were not recorded, and periods longer than 2 to 6 months
would likely be necessary to detect effects of DKA on chronic kidney disease.

Conclusions
This cohort study of AKI during DKA using data from a large, multicenter, prospective study suggests
new hypotheses around the development of kidney injury, and organ injuries in general, during DKA.
Future investigations should focus on mechanisms associated with concurrent injury to the kidneys
and brain. In addition, associations between AKI and long-term kidney dysfunction, including risk of
chronic diabetic kidney disease, should be further investigated. More clearly defining the
mechanisms of kidney injury resulting from DKA could have important implications for the
development of new therapeutic and preventive strategies.
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